The Use of Medicinal Leeching in Breast Surgery: A Systematic Review
Systematic review published in J Clin Med (2024)
Abstract
Background: The medicinal leech has been used in plastic surgery to resolve venous congestion that can threaten the viability of tissue transfer. Within the context of breast surgery, venous congestion is a pertinent consideration for reconstructive and non-reconstructive breast surgery such as mammoplasty and mastopexy. However, leeching is closely associated with complications such as infection, pain, and anaemia. This is the first systematic review that examines the methodology, efficacy, and post therapeutic outcome data across all existing studies on medicinal leeching in breast surgery. Methods: A systematic search of PubMed and Embase databases from their inception to November 2023 was conducted. Inclusion criteria included studies reporting on the use of leeches to resolve venous congestion in any breast surgery. The JBI Critical Appraisal Checklist for Case Series tool was used for bias analysis. Descriptive statistics were undertaken in Microsoft Excel. Results: A total of 18 studies with a combined sample size of 28 were examined, including 4 case series and 14 case reports. Patients mostly underwent reconstructive breast surgery (75%). The median number of leeches used was two, with a median number of three leeching sessions per day and 3 days of leeching. Medicinal leeching successfully prevented the loss of 75% of all tissue transfers. The complication rate was high at 81.14% and mainly included infection and anaemia. Conclusions: Medicinal leeching is an effective method to relieve venous congestion in breast surgery but must be judiciously used within the clinical context of the patient to maximise efficacy and mitigate harm from complications.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Zusammenfassung
Systematic review of 18 studies (28 patients) of medicinal leeching in breast surgery: 75% tissue salvage with high complication rate (81%) primarily infection and anaemia. Median 2 leeches/session, 3 sessions/day, 3 days total.
Warum dies für die Hirudotherapie relevant ist
Diese systematische Übersichtsarbeit untersuchte 18 Studien (4 Fallserien, 14 Fallberichte) mit insgesamt 28 Patienten, die eine medizinische Blutegeltherapie bei venöser Stauung in der Brustchirurgie erhielten, mit einem medianen Behandlungsschema von zwei Blutegeln pro Sitzung, drei Sitzungen täglich, über drei Tage. Die Blutegeltherapie verhinderte den Verlust von 75 % der Gewebetransfers, jedoch betrug die Komplikationsrate 81,14 %, hauptsächlich Infektionen und Anämie. Die Übersicht ist für ASH unmittelbar relevant und liefert aggregierte Evidenz zur Wirksamkeit und Morbidität der Blutegeltherapie speziell in der Brustchirurgie. Die zugrundeliegende Evidenz besteht überwiegend aus Fallberichten und kleinen Fallserien, und die kombinierte Gesamtstichprobengröße beträgt 28 Patienten.
Zitation
The Use of Medicinal Leeching in Breast Surgery: A Systematic Review.
Rajaram R et al. · Journal of clinical medicine, 2024
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Zur ASH-Bibliothek hinzugefügt: May 27, 2026 · Letzte Aktualisierung der Website: 18. Juni 2026